Cath has significant national and international experience in mergers, acquisitions and disposals. Cath provides a broad range of corporate and commercial advice and works with portfolio and private companies on day-to-day commercial requirements, as well as critical and commercially sensitive transactions where the client it is making a key acquisition or divestment.
Cath's clients include founders and owners, start-ups, listed public companies, multinational groups, Australian subsidiaries of multinational groups and privately held Australian companies.
Advising founder and family-owned businesses to help them to prepare for and execute a liquidity event, including working with a network of other advisors to best position stakeholders for a clean exit at a premium valuation. Whether trade sales, capital raising or private equity, these transactions are often transformational for organisations and career-defining for individuals. Cath has particular experience in competitive bid processes.
Australian corporates (listed and unlisted)
Advising companies on a diverse range of transactions, including roll ups, acquisitions and divestments, as well as supporting day-to-day operational requirements and governance.
Representing international buyers in acquiring Australian targets, often working with a network of international advisors. Working in collaboration with Australian management of Australian subsidiaries of global companies to facilitate transactions that meet Australian norms and standards while satisfying the requirements of international legal teams.
Advising on market-changing acquisitions
We advised the founders of Camp Australia on their sale to Bain Capital
Maddocks advises on Medtech Global divestment and restructure
Maddocks has advised Cereus Holdings Ltd on its sale of New Zealand’s leading medical technology company Medtech Global.
Maddocks advises Capitol Health on capital raising
Maddocks is advising one of Australia’s leading diagnostic imaging companies on a $40 million capital raising
M&A due diligence in the time of COVID-19: What are the ‘hangover’ risks in corporate transactions?
Three key considerations when undertaking the due diligence process for mergers and acquisitions.
Will COVID-19 prevent you from operating? Protecting your business in the face of a global pandemic
What will happen if COVID-19 prevents you from performing your contractual obligations?